ILCA: Genomic and Epigenetic-Based Prediction of Response to Zebularine Therapy in Human Liver Cancer

Activity: Talk or presentation types › Lecture and oral contribution

Jesper Bøje Andersen - Speaker

    International Liver Cancer Association
    Milan, Italy
    2009

    External organisation

    NameUnknown external organisation

    ID: 96522956